By the end of 2021, the market for bio-implants was estimated to be worth approximately US$116.3 billion. By 2032, the market is expected to grow at a rate of 10.1% CAGR and reach a valuation of US$ 126.6 billion.
The global bio-implants market is anticipated to grow at 7.2% CAGR during the forecast period. Increase in prevalence of chronic disorders such as cardiovascular disorders, dental diseases, orthopedic devices disorders, along with rapidly growing geriatric patient pool and rapid technological advancements are key factors driving the global bio-implants market.
Bio-implants are implants for medical or clinical therapy applications, such as prosthetics, porous bone implants, wearable biosensors, and drug delivery devices systems. They are normally implanted for a duration of more than 30 days in the human body. They integrate the human body, material qualities, and bio-implant intactness to fix, support, recreate, or improve the functions of human tissues. The need for bio-implants has increased dramatically due to chronic conditions such as rheumatoid arthritis, cardiovascular illness, and metabolic disorders. Due to an ageing population and a shortage of donor organs in medical treatment, the demand for bio-implants has skyrocketed recently. All these factors are expected to boost the growth of bio-implants market in the next few years.
The global bio-implants market has been segmented based on type, material, origin, and region. Based on type, the global bio-implants market is categorized into cardiovascular implants, dental implants, spinal implants, orthopedic implants, and ophthalmic implants. Orthopedic implants segment held the largest share of global market in 2020. On the basis of material, the global bio-implants market is segmented into ceramics, polymers, alloys, and biomaterials metals. Biomaterial metals segment dominated the global bio-implants market in 2020. Geographically, North America dominated the global bio-implants market in 2020, however, Asia Pacific is expected to be the fastest growing region by 2028.
Key players operating in the global bio-implants market include Medtronic, Arthrex, Inc., Zimmer Biomet, Cochlear, Ltd., St. Jude Medical, Orthofix Holdings, Inc., Straumann, Stryker Corporation, Smith & Nephew and DePuy Synthes among others.
Bio-implants Market Scope
Metrics | Details |
Base Year | 2023 |
Historic Data | 2018-2022 |
Forecast Period | 2024-2032 |
Study Period | 2018-2032 |
Forecast Unit | Value (USD) |
Revenue forecast in 2032 | US$ 126.6 billion |
Growth Rate | CAGR of 10.1% during 2022-2032 |
Segment Covered | Type, Material, Origin, Regions |
Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
Key Players Profiled | Medtronic, Arthrex, Inc., Zimmer Biomet, Cochlear, Ltd., St. Jude Medical, Orthofix Holdings, Inc., Straumann AG, Stryker Corporation, Smith & Nephew and DePuy Synthes among others. |
Key Segments of the Global Bio-implants Market
Type Overview
- Cardiovascular Implants
- Dental Implants
- Spinal Implants
- Orthopedic Implants
- Ophthalmic Implants
Material Overview
- Ceramics
- Polymers
- Biomaterials Metals
- Alloys
Origin Overview
- Autograft
- Allograft
- Xenograft
- Synthetic
Regional Overview
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Reasons for the study
- Increase in prevalence of chronic disorders
- Surging geriatric population across the globe
- Growing preference for minimally invasive procedures
What does the report include?
- The study on the global bio-implants market includes qualitative insights such as drivers, restraints, challenges and opportunities
- Additionally, the market has been evaluated using the Porter’s Five Forces analysis
- The study covers qualitative and quantitative analysis of the market segmented on the basis of type, material, origin, and region.
- Actual market sizes and forecasts have been provided for all the above-mentioned segments
- The study includes the profiles of key players operating in the market
Who should buy this report?
- The report on the global bio-implants market is suitable for all the players across the value chain including raw material suppliers, hospitals & clinics, medical device manufacturers, healthcare organizations, distributors, suppliers and technology geeks
- Venture capitalists and investors looking for more information on the future outlook of the global bio-implants market
- Consultants, analysts, researchers, and academicians looking for insights shaping the global bio-implants market
Frequently Asked Questions (FAQ) :
Bio-implants have been used to restore biological structures of the body since the early twentieth century. Replacement, repair, and restoration of hard tissues such as bones, as well as soft tissues such as organs and skin are major applications of bio-implants. Surging elderly patient pool suffering from age-related chronic disorders requiring surgeries and implants is expected to drive the global bio-implants market. Furthermore, increasing shift to minimally invasive techniques will propel growth of the market in the future. These procedures are performed through smaller incisions rather than large opening leading to lower blood loss and quick recovery of patients. Benefits associated with these less-invasive treatments such as speedy recovery, reduced hospitalization period, curtailed risk of infections and lower operative pain will positively influence market growth over the coming years. Minimally invasive surgeries also reduce the incidence of post-surgical complications thereby stimulating demand. Moreover, constant technological advancements in the bio-implant manufacturing industry, such as laser technology, nanotechnology, and 3D printing offer significant growth opportunities in the future owing to their ability to improve the biocompatibility of such implants.
The global bio-implants market has been segmented based on type, material, origin, and region. Based on type, the global bio-implants market is categorized into cardiovascular implants, dental implants, spinal implants, orthopedic implants, and ophthalmic implants. Orthopedic implants segment held substantial share of the global market in 2020. Increase in adoption of orthopedic implants owing to rise in incidence of orthopedic disorders among adults and geriatric patient pool will drive the growth of the segment. Moreover, dental implants segment is expected to witness a lucrative growth over the next few years.
Based on material, the global the global bio-implants market is segmented into ceramics, biomaterials metals, alloys, and polymers. Biomaterials metals segment grabbed majority of the market share in 2020. Wide adoption of biomaterial metals in dental and joint replacement implants along with benefits offered such as better tensile strength and corrosion resistance are important growth drivers for this segment. Origin-wise, the global bio-implants market is segregated into allograft, xenograft, autograft and synthetic. Allografts are expected to grow at a significant rate during the forecast period.
The global bio-implants market is cumulative to North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the global bio-implants market in 2020, however Asia Pacific is expected to grow at a rapid pace through 2028.
High prevalence of chronic disorders such as orthopedic diseases, cardiac disorders, and dental diseases in the U.S. are major factor expected to drive the growth of the market in the region. The number of surgical procedures requiring implants is increasing, as is the adoption of new technologies in the country. Furthermore, presence of large elderly patient population, coupled with strong foothold of key industry players are other major factors likely to boost the growth of the market in North America.
However, Asia Pacific is expected to grow at a rapid pace over the next few years. There is a strong growth potential in the emerging economies such as India, and China. The rapidly rising geriatric population in countries such as India and China, increase in prevalence of dental and orthopedic diseases along with high unmet clinical needs provide large market for bio-implants. According to the Indian Dental Association (IDA), approximately 30 percent of adults aged 65 and older are edentulous in the country. Furthermore, increase in demand for esthetics will lead to higher acceptance of dental implants, which is further anticipated to boost the growth of the market in the coming years.